S. L. Johnston (London, United Kingdom), G. Rohde (Bochum, Germany)
Impact of influenza antigen specific T cell responses on severity of viral infection in humans
T. Wilkinson, C. Li, K. Staples, B. Nicholas, A. Mann, R. Lambkin Williams, R. Djukanovic, J. Oxford, A. Gilbert, X. Xu (Southampton, Oxford, London, United Kingdom)
|   |
Transforming growth factor beta (TGF-β) augments rhinovirus (RV) replication in primary bronchial epithelial cells (pbecs) through modulation of the innate immune response
N. Bedke, D. Sammut, B. Green, P. Howarth, S. Holgate, D. Davies (Southampton, United Kingdom)
| |
Proinflammatory effects of interferon beta (IFNβ) in virally infected bronchial epithelial cell cultures
J. Cakebread, Y. Xu, D. Sammut, P. Howarth, S. Holgate, D. Davies (Southampton, United Kingdom)
| |
Influenza infection of monocyte-macrophages is insensitive to inhibition by NH4Cl
K. J. Staples, C. W. Bragg, B. Nicholas, T. M. A. Wilkinson, R. Djukanovic (Southampton, United Kingdom)
| |
Seasonal patterns, (2004-2007) of respiratory viruses isolated with acute airways disease
P. Wark, M. Tooze, K. Parsons, T. Grissell, J. Ryan (Newcastle, New Lambton, Melbourne, Australia)
| |
IL-4 modulation of rhinovirus-induced CCL20/MIP-3a production in bronchial epithelial cells
G. N. Feketea, A. G. Telcian, M. R. Edwards, L. A. Stanciu, S. L. Johnston (London, United Kingdom; Amaliada, Greece)
| |
Rhinovirus infection differentially modulates MHC class I-related chain (MIC) A and B molecules in human respiratory epithelial cells
L. A. Stanciu, N. Rushwan, A. Telcian, M. T. Zdrenghea, S. L. Johnston (London, United Kingdom)
| |
Low avidity plus IgM positivity indicates active adenovirus infection
M. Gencay, D. Stolz, H. Ahokoski, M. Tamm, M. Roth (Basel, Switzerland; Helsinki, Finland)
| |
Human metapneumovirus, new agent of low respiratory infection, in infants hospitalized in Valparaiso, Chile
A. Milinarsky, T. Henriquez, V. Lezana, L. Jenny, V. Rodrigo (Valparaiso, Chile)
| |
Anti-rhinoviral activity of soluble ICAM-1/FC fusion protein in primary airway epithelial cells from COPD patients
Y. Z. Liu, W. Merrison, C. Jones, D. Lowe, J. Nixon, N. Williams (Loughborough, Cambridge, United Kingdom)
| |
Impact of the presence of serum neutralising antibodies on recruitment into experimental rhinovirus infection studies in asthmatic subjects
S. Field, R. Pestridge, J. Roberts, V. Tear, C. Boxall, P. Monk (Southampton, United Kingdom)
| |
Effector memory CD8+T cell responses to RSV infected respiratory epithelial cells
A. Telcian, L. Stanciu, S. Johnston (London, United Kingdom)
| |
Use of a multiplex real-time PCR for differential diagnosis of respiratory viral infections
A. Nikonova, S. Lobodanov, A. Oksanich, E. C. J. Claas, V. Zverev, E. Faizuloev (Moscow, Russian Federation; Leiden, Netherlands)
| |
Induction of alpha-, beta- and lambda-interferons upon respiratory virus infection in vitro
M. Khaitov, M. Edwards, L. Stanciu, G. Rohde, S. Johnston (Moscow, Russian Federation; London, United Kingdom; Bochum, Germany)
| |
Prevalence of respiratory viruses in sputum collected in a Dutch university hospital, 2003-2008
R. Deurenberg, P. Wolffs, I. van Loo, C. Bruggeman (Maastricht, Netherlands)
| |
The methods of detection and study of influenza viruses, antibodies to them in Russia
S. Trushakova, V. Ivanova, T. Oskerko, A. Minenko, E. Shevchenko, E. Burtseva (Moscow, Russian Federation)
| |
Viral upper respiratory infection and acute asthma exacerbation
G. Moskovljevic, J. Moskovljevic (Varvarin, Nis, Republic Of Serbia)
| |
Cell surface expression of α2,3 and α2,6 sialic acids does not determine susceptibility of human cell lines to influenza infection
B. Nicholas, K. Staples, T. Wilkinson, R. Djukanovic (Southampton, United Kingdom)
| |
Prevalence of respiratory viral infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review
S. Chandra, D. Agarwal, V. Singh, A. Mohan, R. Guleria, R. Pandey (New Dlehi, New Delhi, India; Rochester, United States Of America)
| |
Detection of antibody response against influenza vaccine in patients with chronic obstructive pulmonary disease (COPD) by quantitative ELISA and evalution of clinical findings
C. Anar, C. Biçmen, S. Yapicioglu, H. Halilçolar, I. Ünsal, U. Yilmaz (Izmir, Turkey)
| |